Can procalcitonin be useful for medullary thyroid cancer?

Endokrynologia Polska

Volumn 61, Issue 5, 2010, Pages 430-436

  Kaczka, Krzysztof ^a   Mikosiński, Sławomir ^b   Fendler, Wojciech ^a   Jałocha Kaczka, Anna ^a   Pomorski, Lech ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Department of Nuclear Medicine and Oncological Endocrinology   (Poland)

Author keywords

Calcitonin; Diagnostic marker; Medullary thyroid cancer; Procalcitonin

Indexed keywords

CALCITONIN; PROCALCITONIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER REGRESSION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; LIVER METASTASIS; MALE; NODULAR GOITER; REOPERATION; THYROID HORMONE BLOOD LEVEL; THYROID MEDULLARY CARCINOMA;

CALCITONIN; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTEIN PRECURSORS; REMISSION INDUCTION; REOPERATION; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 78650016369     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Constante G, Merongolo D, Durante C et al. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007; 92: 450-455.
2. Pacini F, Fontanelli M, Fugazzola L et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected medullary thyroid carcinoma. J Clin Endocrinol Metab 1994; 78: 826-829. (Pubitemid 24118072)
3. Rieu M, Lame MC, Richard A et al. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf) 1995; 42: 453-460.
4. Niccoli P, Wion-Barbot N, Caron P et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J Clin Endocrinol Metab 1997; 82: 338-341. (Pubitemid 27068587)
5. Lew-Bohbot N, Patey M, Larbre M et al. How to interprete hypercalcitonemia. Rev Med Interne 2006; 27: 610-615.
6. Iacobone M, Niccoli-Sire P, Sebag F et al. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg 2002; 26: 886-890. (Pubitemid 36920281)
7. Silva OL, Broder LE, Doppman JL et al. Calcitonin as a marker for bronchogenic cancer: a prospective study. Cancer 1979; 44: 680-684.
8. Algecitras-Schimnich A, Preissner C, Theobald P, Finseth MS, Grebe SK, Procalcitonin: a marker forthe diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrin Metab. 2008; 94: 861-868.
9. Akan B, Bohmig G, Sunder-Plassmann G, Borchhardt KA. Prevalence of hypercalcitoninemia in patients on maintenance dialysis referred to kidney transplantation. Clin Nephrol 2009; 71: 538-542.
10. Fugazzola AL, Pinchera A, Luchetti F et al. Disappearance rate of serum calcitonin after total thyroidectomy for medullary thyroid carcinoma. Int J Biol Markers 1994; 9: 21-24. (Pubitemid 24135513)
11. Pomorski L, Cywiński J, Kołomecki K, Pasieka Z, Bartos M, Kuzdak K. Recurrences of thyroid cancer after radical surgery and complementary treatment: are macroscopic, microscopic, scintigraphic, and biochemical criteria sufficient in the evaluation of radicality of primary treatment? Recent Results Cancer Res. 2003; 162: 203-207.
12. Becker KL, Snider RH, Silva OL, Moore CF. Calcitonin heterogeneity in lung and medullary thyroid cancer. Acta Endocrinologica 1978; 89: 89-99. (Pubitemid 9014654)
13. Tomamsi M, Brocchi A, Cappellini A, Raspanti S, Mannelli M. False serum calcitonin high levels using a non-competitive two-site IRMA. J Endocrinol Invest 2001; 24: 356-360. (Pubitemid 32492373)
14. Cole TG, Johnson D, Eveland BJ, Nahm MH. Cost-effective method for detection of "hook effect" in tumor marker immunometric assays. Clin Chem 1993; 39: 695-696.
15. Leboeuf R, Langlois MF, Martin M, Ahnadi CE, Fink GD, "Hook Effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature. J Clin Endocrin Metab. 2006; 91: 361-364.
16. Leboulleux S, Baudin E, Travagli JP et al. Medullary thyroid carcinoma. 2004; 61: 299-310.
17. Morimoto S, Onishi T, Takamoto S et al. Interference in radioimmunoassay of human calcitonin by vitamin C and urea. Med J Osaka Univ 1985; 35: 77-82. (Pubitemid 16231897)
18. Dahaba AA, Metzler H. Procalcitonin«s role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator? Minerva Anestesiol 2009; 75: 447-452.
19. Mueller B, White JC, Nylen ES et al. Ubiquitous expression of the calcitonin-1 gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001; 86: 396-404.
20. Fendler WM, Piotrowski AJ. Procalcitonin in the early diagnosis of nosocomial sepsis in preterm neonates. J Paediatr Child Health 2008; 44: 114-118. (Pubitemid 351326864)
21. Meisner M, Schmidt J, Hüttner H, Tschaikowski K. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000; 26 (Suppl. 2): S21 12-16.
22. Meisner M, Tschaikowsky K, Schnabel S et al. Procalcitonin - influence of temperature, storage, anticoagulation and arterial or venous assentation of blood samples on procalcitonin concentrations. Eur J Clin Chem Clin Biochem 1997; 35: 597-601. (Pubitemid 27387071)
23. Szawłowski AW, Schmidt J. The rules in diagnosis and surgical treatment of neoplasms in Poland (in Polish). Foundation - the Polish Journal of Surgery, Warsaw, 2003.
24. Hasselgren M, Hegedüs L, Godballe C et al. Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules. Head Neck 2010; 32: 612-618.
25. Hahm JR, Lee MS, Min YK et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001; 11: 73-80.
26. Papi G, Corsello SM, Cioni K et al. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study. J Endocrinol Invest 2006; 29: 427-437. (Pubitemid 44043359)
27. Martinetti A, Seregni E, Ferrari L et al. Evaluation of circulating calcitonin analytical aspects. Tumori 2003; 89: 566-568. (Pubitemid 37541622)
28. Baloch Z, Carayon P, Conte-Devolx B et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3-126.
29. Matzaraki V, Alexandraki KI, Venetsanou K et al. Evaluation of serum procalcitonin and interleukin-6 levels markers of liver metastasis. Clin Biochem 2007; 40: 336-342.